Role of macrophage in nanomedicine-based disease treatment

Drug Deliv. 2021 Dec;28(1):752-766. doi: 10.1080/10717544.2021.1909175.

Abstract

Macrophages are a major component of the immunoresponse. Diversity and plasticity are two of the hallmarks of macrophages, which allow them to act as proinflammatory, anti-inflammatory, and homeostatic agents. Research has found that cancer and many inflammatory or autoimmune disorders are correlated with activation and tissue infiltration of macrophages. Recent developments in macrophage nanomedicine-based disease treatment are proving to be timely owing to the increasing inadequacy of traditional treatment. Here, we review the role of macrophages in nanomedicine-based disease treatment. First, we present a brief background on macrophages and nanomedicine. Then, we delve into applications of macrophages as a target for disease treatment and delivery systems and summarize the applications of macrophage-derived extracellular vesicles. Finally, we provide an outlook on the clinical utility of macrophages in nanomedicine-based disease treatment.

Keywords: Macrophage; drug delivery; nanomedicine.

Publication types

  • Review

MeSH terms

  • Biological Availability
  • Chemistry, Pharmaceutical
  • Drug Delivery Systems / methods*
  • Extracellular Vesicles / metabolism
  • Inflammation Mediators / metabolism
  • Macrophages / physiology*
  • Major Histocompatibility Complex / immunology
  • Nanomedicine / methods*
  • Neoplasms / drug therapy
  • Neoplasms / immunology

Substances

  • Inflammation Mediators

Grants and funding

This work was supported by the National Natural Science Foundation of China [82070099].